These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 34958060)

  • 1. Stromal expression of CD10 in invasive breast carcinoma and its association with tumour stage, grade, ER, PR and HER2 status.
    Kamarudin NA; Abd Shukor N; Farouk WI; Muhammad Hanapi NA; Mohammed F
    Malays J Pathol; 2021 Dec; 43(3):389-396. PubMed ID: 34958060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.
    Makretsov NA; Hayes M; Carter BA; Dabiri S; Gilks CB; Huntsman DG
    Mod Pathol; 2007 Jan; 20(1):84-9. PubMed ID: 17143263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD10-a new prognostic stromal marker in breast carcinoma, its utility, limitations and role in breast cancer pathogenesis.
    Jana SH; Jha BM; Patel C; Jana D; Agarwal A
    Indian J Pathol Microbiol; 2014; 57(4):530-6. PubMed ID: 25308002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal Expression of CD10 in Invasive Breast Carcinoma and Its Correlation with ER, PR, HER2-neu, and Ki67.
    Puri V; Jain M; Thomas S
    Int J Breast Cancer; 2011; 2011():437957. PubMed ID: 22295223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal expression of CD10 in breast carcinoma and its correlation with clinicopathological parameters.
    Dhande AN; Sinai Khandeparkar SG; Joshi AR; Kulkarni MM; Pandya N; Mohanapure N; Aggarwal A; Patil G
    South Asian J Cancer; 2019; 8(1):18-21. PubMed ID: 30766845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy.
    Olah O; Majlat E; Koszo R; Vereb Z; Voros A
    Pathol Oncol Res; 2022; 28():1610598. PubMed ID: 36685105
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of neoadjuvant chemotherapy on stromal CD10 antigens in breast cancer - a preliminary study.
    Thomas S; Babu RJ; Agarwal K; Puri V; Jain M; Andley M; Tudu SK
    Indian J Cancer; 2013; 50(1):46-51. PubMed ID: 23713046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
    Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
    Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer.
    Park C; Park K; Kim J; Sin Y; Park I; Cho H; Yang K; Bae BN; Kim KW; Ahn S; Gwak G
    World J Surg Oncol; 2016 Sep; 14(1):244. PubMed ID: 27619909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stromal CD10 expression and relationship to the E-cadherin/beta-catenin complex in breast carcinoma.
    Kim HS; Kim GY; Kim YW; Park YK; Song JY; Lim SJ
    Histopathology; 2010 May; 56(6):708-19. PubMed ID: 20546336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical Expression of BRCA1 Protein, ER, PR and Her2/neu in Breast Cancer: A Clinicopathological Study.
    Hussein IA; Ahmed ST; Hameedi AD; Naji RZ; Alharbawi L; Alkhaytt M; Pity IS
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1025-1029. PubMed ID: 32334465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas.
    Fernandes RC; Bevilacqua JL; Soares IC; Siqueira SA; Pires L; Hegg R; Carvalho FM
    Histopathology; 2009 Sep; 55(3):346-52. PubMed ID: 19723150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal Expression of CD10 in Breast Carcinoma and Its Association with Known Prognostic Factors-A Tissue Microarray-Based Study.
    Gaffoor N; Krishnamurthy J
    J Lab Physicians; 2023 Sep; 15(3):354-360. PubMed ID: 37564218
    [No Abstract]   [Full Text] [Related]  

  • 14. Stromal microenvironment namely angiogenesis, tumor-infiltrating lymphocytes, and matrix metalloproteinase in invasive breast carcinoma: Do they have a prognostic role?
    Srivastava G; Pant L; Kudesia M; Singh S; Gupta R
    J Cancer Res Ther; 2022; 18(6):1733-1737. PubMed ID: 36412437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
    Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
    BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
    Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
    Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.
    Senel F
    Indian J Pathol Microbiol; 2021; 64(4):671-676. PubMed ID: 34673584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients.
    Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V
    Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes of Immunohistochemically Defined Subtypes of Breast Cancer Less Than or Equal to 2 cm After Breast-Conserving Surgery.
    Pata G; Guaineri A; Bianchi A; Amoroso V; Pasinetti N; Pasini M
    J Surg Res; 2019 Apr; 236():288-299. PubMed ID: 30694768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.